[PDF][PDF] Role of high-sensitivity C-reactive protein (Hs-CRP) in non-communicable diseases: a review

T Banait, A Wanjari, V Danade, S Banait, J Jain - Cureus, 2022 - cureus.com
Non-communicable diseases like cardiovascular diseases, cerebrovascular diseases,
diabetes mellitus, and cancer are very common causes of death worldwide. Therefore, the …

[HTML][HTML] Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study

F Zibaeenejad, SS Mohammadi, M Sayadi… - BMC Cardiovascular …, 2022 - Springer
Background Atherosclerotic cardiovascular disease (ASCVD) continues to be the first cause
of mortality globally. Effective preventive strategies require focused efforts to clarify ASCVD …

[HTML][HTML] High sensitivity C-reactive protein predictive value for cardiovascular disease: a nested case control from Isfahan cohort study (ICS)

P Koosha, H Roohafza, N Sarrafzadegan… - Global Heart, 2020 - ncbi.nlm.nih.gov
Background: High sensitivity C-reactive protein (hs-CRP) was proven to be an independent
risk factor for cardiovascular diseases (CVDs). The aim of this study was to investigate the …

[HTML][HTML] Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism

Z Zhang, J Wang, Y Zhu… - Molecular medicine …, 2019 - spandidos-publications.com
The aim of the present study was to evaluate the protective effect and mechanism of
Astragaloside IV (ASIV) on myocardial injury induced by type 2 diabetes, with a focus on …

[HTML][HTML] Estimation of the 10-year risk of cardiovascular diseases: using the SCORE, WHO/ISH, and Framingham models in the Shahrekord cohort study in …

PS Bavarsad, S Kheiri, A Ahmadi - The Journal of Tehran …, 2020 - ncbi.nlm.nih.gov
Background: Predicting the risk of cardiovascular diseases (CVDs) helps the management
of high-risk individuals by the health system. We sought to determine the 10-year risk of …

Metolazone Add‐On Therapy in Heart Failure: A Cohort Study from Persian Registry of Cardiovascular Disease/Heart Failure (PROVE/HF)

F Rahimi, M Vakhshoori, M Heidarpour… - … Care Research and …, 2021 - Wiley Online Library
Background. One of the strategies for overcoming diuretic resistance among heart failure
(HF) patients is adding thiazide‐type diuretics. The main aim of this article is to compare the …

[HTML][HTML] Design and methodology of heart failure registry: results of the Persian registry of cardiovascular disease

M Givi, K Heshmat-Ghahdarijani… - Arya …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Heart failure (HF) resulted from ultimate pathway of many cardiovascular
diseases (CVDs) or as a separate entity poses a considerable increasing prevalence and …

[HTML][HTML] The effect of sedentary time on cardiovascular disease risk in middle-aged and elderly patients with type 2 diabetes mellitus

W Jia, W He, Q Cui, X Ye, H Qian - Medicine, 2023 - journals.lww.com
Sedentary lifestyle has become quite prevalent lately, and it has been associated with
cardiovascular diseases (CVDs). CVD is a primary cause of premature death in patients with …

Body composition and the components of metabolic syndrome in type 2 diabetes: the roles of disease duration and glycemic control

MMA Abulmeaty, GS Aljuraiban… - Diabetes, Metabolic …, 2020 - Taylor & Francis
Purpose Data about body compositional changes throughout the course of type 2 diabetes
(T2D) are limited and inconsistent. We investigated the roles of the disease duration and …

[PDF][PDF] Frequency of readmission in Iranian heart failure patients within six months after discharge and its association with guideline directed medical treatment

M Hoseinbor, M Vakhshoori, A Babak, M Givi… - Age (years), 2019 - researchgate.net
ABSTRACT Background and Aims: Assessment of heart failure (HF) therapy based on
guideline was less frequently performed. Objectives: In this study, we aimed to evaluate the …